Vijayan V, Ho J, Goh H S
Department of Colorectal Surgery, Singapore General Hospital.
Ann Acad Med Singap. 1995 May;24(3):347-52.
Abnormal DNA content or aneuploidy in cells usually indicates malignancy. In colorectal cancer aneuploidy has been shown to confer a poorer prognosis suggesting that aneuploid cancers are more aggressive. The mechanisms involved in the aggressive behaviour of an aneuploid tumour are still unknown. The aim of this study was to compare the patterns of aneuploidy of colorectal cancers and that of their corresponding lymph node metastases and to relate them to clinical outcomes. One hundred and one patients were studied, 81 (Dukes C) with lymph node metastasis only and 20 (Dukes D) with obvious distant metastasis as well. Forty-six (46.5%) of the tumours and an equal number of the lymph nodes were found to be aneuploid. Twenty-eight (60.9%) of the aneuploid tumours showed aneuploid metastasis and 18 (39.1%) showed diploid metastasis. Similarly, 37 (67.3%) of the diploid tumours showed diploid metastasis whereas 18 (32.7%) showed aneuploid metastasis. Local recurrence and distant metastasis were compared among the aneuploid and diploid primary tumours. Although there was no statistically significant difference, distant metastasis was more common in aneuploid tumour. Ploidy of the lymph node was not related to local recurrence or distant metastasis. We conclude that DNA ploidy by itself does not determine the metastatic potential of the tumour cell and that in about 50% of the tumours, the lymph node metastasis consists of clones of cells different from the primary tumours. We also conclude that the clinical outcome of the disease in terms of recurrence and metastasis cannot be predicted by the ploidy of the lymph node metastatic lesions.
细胞中异常的DNA含量或非整倍体通常表明存在恶性肿瘤。在结直肠癌中,非整倍体已被证明与较差的预后相关,这表明非整倍体癌症更具侵袭性。非整倍体肿瘤侵袭性行为所涉及的机制仍然未知。本研究的目的是比较结直肠癌及其相应淋巴结转移灶的非整倍体模式,并将它们与临床结果相关联。对101例患者进行了研究,其中81例(Dukes C期)仅伴有淋巴结转移,20例(Dukes D期)还伴有明显的远处转移。发现46例(46.5%)肿瘤和相同数量的淋巴结为非整倍体。28例(60.9%)非整倍体肿瘤显示非整倍体转移,18例(39.1%)显示二倍体转移。同样,37例(67.3%)二倍体肿瘤显示二倍体转移,而18例(32.7%)显示非整倍体转移。比较了非整倍体和二倍体原发性肿瘤的局部复发和远处转移情况。虽然没有统计学上的显著差异,但远处转移在非整倍体肿瘤中更常见。淋巴结的倍性与局部复发或远处转移无关。我们得出结论,DNA倍性本身并不能决定肿瘤细胞的转移潜能,并且在大约50%的肿瘤中,淋巴结转移由与原发性肿瘤不同的细胞克隆组成。我们还得出结论,疾病在复发和转移方面的临床结果不能通过淋巴结转移灶的倍性来预测。